Lupus nephritis (LN) is clinically evident in 50–75% of lupus patients and is a significant
cause of end-stage renal disease. Although LN is a paradigm of immune complex–mediated …

Lupus nephritis (LN) is clinically evident in 50 to 75% of patients with systemic lupus
erythematosus and is a significant cause of ESRD. Although LN is a paradigmatic example …

The treatment of lupus nephritis has changed significantly over the past decade in large part
because of data from well-conducted randomized clinical trials. The concept of two phases …

Lupus nephritis (LN) is an inflammatory condition of the kidneys that encompasses various
patterns of renal disease including glomerular and tubulointerstitial pathology. It is a major …

The collaborative efforts of patients, clinical and translational researchers, the
pharmaceutical industry and funding sources are needed to advance therapies for lupus …

Renal involvement in systemic lupus erythematosus patients is a severe disease
manifestation characterized by various clinical and histopathological alterations. The revised …

Systemic lupus is the prototypic human autoimmune disease. It is a kaleidoscope of
autoreactivities, with clear indications of both a genetic and environmental basis. Indeed, it is …

Background: Lupus nephritis (LN) is a common complication in many patients with systemic
lupus erythematosus, although renal-limited lupus nephritis has been reported as well. Early …

Lupus Nephritis (LN) is a common and severe manifestation of systemic lupus
erythematosus (SLE), impacting up to 40% of SLE patients. Despite advancements in …

Systemic lupus erythematosus may present with renal manifestations that frequently are
difficult to categorize and lupus nephritis is an important predictor of poor outcome. The type …